Larry Mattheakis - Feb 11, 2022 Form 4 Insider Report for Annexon, Inc. (ANNX)

Role
EVP & Chief Scientific Officer
Signature
/s/ Jennifer Lew, as Attorney-in-Fact for Larry Mattheakis
Stock symbol
ANNX
Transactions as of
Feb 11, 2022
Transactions value $
$0
Form type
4
Date filed
2/15/2022, 03:35 PM
Previous filing
Oct 4, 2021
Next filing
Jul 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANNX Common Stock Award $0 +12.5K $0.00 12.5K Feb 11, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANNX Stock Option (Right to Buy) Award $0 +100K $0.00 100K Feb 11, 2022 Common Stock 100K $6.94 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on February 11 of each year, with the first 1/3rd vesting on February 11, 2023.
F2 Includes 12,500 RSUs.
F3 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 11, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.